3002.13.00.90/Denosumab Drug Substance/Japan

Denosumab Drug Substance from Japan

Denosumab is RANKL inhibitor monoclonal antibody for osteoporosis and cancer bone metastases. HTS 3002.13.0090 unmixed immunological product. Bulk biotech supply.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Bone metabolism marker correlation data

• Refrigerated bill of lading mandatory

• No retail intent declaration

Denosumab Drug Substance from Japan — Import Duty Rate | HTS 3002.13.00.90